U.S. Stock Market Daily — 2026-05-29
U.S. markets stayed strong over the past 24 hours, with the Fear & Greed Index hitting 60.14, signaling a shift toward moderate optimism. Hopes for U.S.-Iran peace talks and falling oil prices are really driving the gains.
U.S. Stock Market Daily — 2026-05-29
Fear & Greed Index
The current index stands at 60.14, indicating that market sentiment is in a "Neutral to Greed" phase. This shows that investors are moving away from extreme fear and settling into a more balanced perception of risk.

Market Highlights
- S&P 500: Trading near all-time highs.
- Dow Jones: Closed at an all-time record high.
- Tech Stocks (NASDAQ): Continued their leadership streak throughout the day.

Key Market Drivers and Macro Environment
-
Oil Price Drop Eases Inflation Worries: Crude oil futures slipped below $90 a barrel, significantly cooling inflation concerns linked to energy costs. This follows optimism regarding U.S.-Iran peace negotiations, fueling hopes that reduced geopolitical tension will lower supply risks.
-
Optimism on U.S.-Iran Peace Talks: Reports of a ceasefire extension agreement between U.S. and Iran negotiators have boosted expectations for a reduction in geopolitical risk, which in turn has spurred a recovery in the tech sector.
-
Fed Policy Uncertainty: Since the start of the Iran conflict, investors have increasingly braced for potential Federal Reserve (Fed) rate hikes. The market, which had previously been exploring the possibility of rate cuts, is now shifting to prepare for potential hikes.
Market Expert Outlook
-
Potential for Short-Term Gains: Major indices are hitting all-time highs with tech stocks leading the way. However, any resurgence in geopolitical tensions or a sharp rebound in energy prices could change the game.
-
Correction Risk Warning: U.S. Bank has issued a warning that a stock market correction could be on the horizon, given the current geopolitical risks and rising market volatility.
-
Individual Stock Analysis: Barclays has upgraded SanDisk (SNDK) to "Overweight," while Jefferies upgraded PTC Therapeutics, citing positive prospects for their Sephience pipeline.
This content was collected, curated, and summarized entirely by AI — including how and what to gather. It may contain inaccuracies. Crew does not guarantee the accuracy of any information presented here. Always verify facts on your own before acting on them. Crew assumes no legal liability for any consequences arising from reliance on this content.